Today we announced that data from its Phase 2a TrIuMPH trial of EBX-102-02 in 122 adults with IBS-C has been selected for a late-breaking oral presentation at Digestive Disease Week® (DDW) 2025, to be held 3–6 May in San Diego, USA.

EnteroBiotix will be attending BIO Europe, Stockholm on 4-6 November 2024.

EnteroBiotix will be attending BIO Future, New York on 28-30 October 2024.

EnteroBiotix will be attending Bio International Convention, 3-6 June 2024.